health pharma news today obesity drugs glp-1 today october 2025 Outlook for obesity in 2025: more A network meta-analysis backed weight-loss
Description
Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity
People who took Zepbound, which is a GLP-1 RA drug, and were diagnosed with NAION can speak to an attorney about whether or not they qualify to join this litigation
The Production Budget: Cost of Ozempic Therapy Ozempic's blockbuster status comes with a hefty price tag - and our other GLP-1 options arent too cheap either
Trials are also now being planned or conducted on cocaine-use disorder and opioids
GreenJBBethelMAArmstrongPWBuseJBEngelSSGargJet al
